Yang YF - Search Results

1

CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma.

Yang YF, Pan YH, Tian QH, Wu DC, Su SG. Yang YF, et al. Transl Oncol. 2018 Oct;11(5):1110-1118. doi: 10.1016/j.tranon.2018.07.002. Epub 2018 Jul 19. Transl Oncol. 2018. PMID: 30031230 Free PMC article.

2

Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.

Zhang MF, Zhang ZY, Fu J, Yang YF, Yun JP. Zhang MF, et al. Among authors: yang yf. J Transl Med. 2009 Dec 22;7:110. doi: 10.1186/1479-5876-7-110. J Transl Med. 2009. PMID: 20025780 Free PMC article.

3

Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment.

Yang YF, Liao YY, Liu XL, Su SG, Li LZ, Peng NF. Yang YF, et al. Gynecol Oncol. 2015 Dec;139(3):419-23. doi: 10.1016/j.ygyno.2015.10.015. Epub 2015 Oct 19. Gynecol Oncol. 2015. PMID: 26494424

4

PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.

Yang YF, Pan YH, Cao Y, Fu J, Yang X, Zhang MF, Tian QH. Yang YF, et al. Among authors: yang x. Oncotarget. 2017 Jul 18;8(29):47195-47205. doi: 10.18632/oncotarget.17587. Oncotarget. 2017. PMID: 28525379 Free PMC article.

5

CEP131 indicates poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma.

Liu XH, Yang YF, Fang HY, Wang XH, Zhang MF, Wu DC. Liu XH, et al. Among authors: yang yf. Int J Biochem Cell Biol. 2017 Sep;90:1-8. doi: 10.1016/j.biocel.2017.07.001. Epub 2017 Jul 8. Int J Biochem Cell Biol. 2017. PMID: 28694105

6

TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.

Yang YF, Zhang MF, Tian QH, Zhang CZ. Yang YF, et al. J Cell Sci. 2017 Sep 15;130(18):3108-3115. doi: 10.1242/jcs.206623. Epub 2017 Jul 28. J Cell Sci. 2017. PMID: 28754688

7

SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.

Yang YF, Zhang MF, Tian QH, Fu J, Yang X, Zhang CZ, Yang H. Yang YF, et al. Among authors: yang x, yang h. Mol Cancer. 2018 Aug 8;17(1):117. doi: 10.1186/s12943-018-0872-3. Mol Cancer. 2018. PMID: 30089483 Free PMC article.

8

FMNL1 Exhibits Pro-Metastatic Activity via CXCR2 in Clear Cell Renal Cell Carcinoma.

Zhang MF, Li QL, Yang YF, Cao Y, Zhang CZ. Zhang MF, et al. Among authors: yang yf. Front Oncol. 2020 Nov 26;10:564614. doi: 10.3389/fonc.2020.564614. eCollection 2020. Front Oncol. 2020. PMID: 33324547 Free PMC article.

9

FOXK2, regulted by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma.

Lin MF, Yang YF, Peng ZP, Zhang MF, Liang JY, Chen W, Liu XH, Zheng YL. Lin MF, et al. Among authors: yang yf. Int J Biochem Cell Biol. 2017 Jul;88:155-161. doi: 10.1016/j.biocel.2017.05.019. Epub 2017 May 12. Int J Biochem Cell Biol. 2017. PMID: 28506857

10

PBK/TOPK promotes chemoresistance to oxaliplatin in hepatocellular carcinoma cells by regulating PTEN.

Cao H, Yang M, Yang Y, Fang J, Cui Y. Cao H, et al. Acta Biochim Biophys Sin (Shanghai). 2021 Apr 15;53(5):584-592. doi: 10.1093/abbs/gmab028. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 33772548 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,423 results

Search Page

Filters